Indomethacin abolishes cerebral blood flow increase in response to acetazolamide-induced extracellular acidosis: a mechanism for its effect on hypercapnia?

J Cereb Blood Flow Metab. 1993 Jul;13(4):724-7. doi: 10.1038/jcbfm.1993.92.


Indomethacin is known to attenuate quite markedly the increase in CBF during hypercapnia. Hypercapnia is, in all likelihood, mediated by the acid shift at the level of the smooth muscle cells of the cerebral arterioles. We therefore investigated the effect of indomethacin on the CBF increase caused by acetazolamide (Az), a drug that induces brain extracellular acidosis, which triggers its effect on CBF. We compared the results to the inhibitory effect of indomethacin on the CBF increase during hypercapnia. Indomethacin but not diclofenac, another potent cyclooxygenase inhibitor, was found to block almost completely the CBF increase caused by Az-induced extracellular acidosis or by CO2, but it did not influence the CBF increase produced by sodium nitroprusside or papaverine. The results suggest that indomethacin exerts its action on CO2 reactivity by a nonprostaglandin-mediated mechanism that directly interferes with the regulation of cerebrovascular tone mediated by extracellular pH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetazolamide / pharmacology*
  • Acidosis / physiopathology*
  • Animals
  • Carbon Dioxide / pharmacology
  • Cerebrovascular Circulation / drug effects*
  • Diclofenac / pharmacology
  • Extracellular Space / metabolism*
  • Hypercapnia / physiopathology*
  • Indomethacin / pharmacology*
  • Male
  • Rats
  • Rats, Wistar


  • Carbon Dioxide
  • Diclofenac
  • Acetazolamide
  • Indomethacin